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Purpose: Adherence to inhalation therapy is a critical determinant of the success of chronic 
obstructive pulmonary disease (COPD) management. However, in practice, nonadherence to 
inhalation therapy is very common in COPD patients. The effects of adherence to inhalation 
therapy in COPD have not been fully studied, and less is known about the relationship between 
medication adherence and quality of life in COPD. Our aim is to assess the factors that contribute 
to adherence to inhalation therapy and examine their correlation with quality of life.
Patients and methods: A cross-sectional analysis of 88 COPD patients was performed using 
a self-reported adherence questionnaire with responses on a 5-point Likert scale.
Results: Of the 88 patients who were potential participants, 55 (63%) responded with usable 
information. The only significant factor associated with the overall mean adherence score was 
receiving repeated instruction about inhalation techniques (P = 0.032). Of the 55 respondents, 22 
(40.0%) were given repeated verbal instruction and/or demonstrations of inhalation technique by 
a respiratory physician. Significant correlations were found between the overall mean adherence 
score and the health-related quality of life score (St George’s Respiratory Questionnaire: total, 
r = −0.35, P = 0.023; symptoms, r = −0.43, P = 0.002; impacts, r = −0.35, P = 0.011). Further-
more, patients with repeated instruction showed better quality of life scores than those who did 
not receive instruction (total, P = 0.030; symptoms, P = 0.038; impacts, P = 0.019).
Conclusions: Repeated instruction for inhalation techniques may contribute to adherence to 
therapeutic regimens, which relates to better health status in COPD.
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Introduction
Chronic obstructive pulmonary disease (COPD) is the fourth most common global 
cause of death. Its prevalence is expected to increase, and it results in substantial 
social and economic burdens.1 Numerous studies have shown that COPD therapy 
achieves several of the goals of COPD management, including prevention and control 
of symptoms, reduction in the rates of exacerbation and hospitalization, and improve-
ment of health-related quality of life (HRQL).2 Inhalation therapy plays a central role 
in COPD therapy, but it is widely recognized that many patients do not always adhere 
to their inhalation regimens. Several studies have reported that an average of 60% of 
COPD patients do not adhere to prescribed therapy.3–5 Furthermore, patients make a 
number of errors with inhaler handling, some of which are critical to the efficacy of 
inhalation treatment.6International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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Adherence to inhaled medication in COPD may impact on 
clinical outcomes. Recently, Vestbo et al reported that among 
moderate to severe COPD patients enrolled in the Towards a 
Revolution in COPD Health study, there was a strong associa-
tion between adherence to inhaled medicine and mortality, 
as well as risk of hospitalization due to exacerbations. They 
found that the mortality of nonadherent patients was more 
than twice that of adherent patients, with adherence defined 
as .80% use of study medication.7
Adherence to inhalation therapy is complex, influenced 
by multiple aspects, including patient factors (eg, sex, age, 
and comorbidities), different types of therapy regimens 
(eg, polypharmacy, frequency of dosing, and type of inhaler 
devices), and the quality of communication between health 
care providers and patients.8 We previously studied adherence 
to inhalation therapy of adult patients with asthma and 
showed a significant relationship between repeated instruc-
tion on inhalation technique and good adherence to inhalation 
therapy. Furthermore, patients who had good adherence to 
inhalation therapy showed better HRQL.9 COPD patients, 
as well as asthmatic patients, have multiple factors that may 
affect adherence to therapy and therapeutic outcomes, but 
factors affecting adherence to inhalation therapy in COPD 
have not been fully addressed, and less is known regarding 
the relationship of medication adherence to quality of life, 
which is one of the important clinical outcomes that represent 
patient-centered measures of disease control in COPD.10
The aim of this study was to identify the factors that con-
tribute to adherence to inhalation therapy and to investigate 
the relationships among these factors, adherence, and quality 
of life in patients with COPD.
Methods
study design
This was a cross-sectional questionnaire study. To elucidate 
the patient-related aspects of adherence to inhalation therapy 
in COPD patients, effects of age, sex, duration of COPD, 
presence of comorbidities, prescribed antipsychotic drugs, 
frequency of consultations, duration of inhaled medicine 
use, type of inhaler devices (dry powder inhaler [DPI] or 
metered-dose inhaler [MDI] or both DPI + MDI), frequency 
of administration of inhaled medicine, stage of COPD, and 
presence or absence of repeated instruction for inhalation tech-
nique were examined. The relationship between   adherence 
to inhalation therapy and health status assessed by a HRQL 
questionnaire was also examined. The survey for this study 
was performed from November 2006 through March 2007.
subjects
A total of 88 consecutive outpatients with COPD were 
recruited from the respiratory clinic of Kitano   Hospital 
  Medical Research Institute. Subjects were eligible for 
participation in the study if they met the following 
criteria: 1) current or former smoker (.10 pack-years); 
2) regular visits to respiratory outpatient clinic every 
1–3 months; 3) respiratory physician diagnosed COPD; 
4) prescribed inhaled medicines (anticholinergic, β2 agonist, 
or inhaled corticosteroid) for at least 12 months; and 5) no 
change in COPD inhaler medication for 3 months. Patients’ 
data were obtained from their medical records. The diagnosis 
and staging of COPD were confirmed by the lung function 
criteria of the GOLD guideline.1
The research protocol was approved by the Institu-
tional Review Board of Kitano Hospital Medical Research 
Institute.
Questionnaire on inhalation therapy
The questionnaire survey was carried out as previously 
described.9 Briefly, on the day of their appointment with 
the respiratory physician, potential study participants were 
approached in the waiting room by the researcher and invited 
to answer a brief questionnaire prior to their   appointment. 
The adherence questionnaire was a modification of a scale 
developed to measure self-reported adherence to inhaled 
medication.9,11,12 This scale included the four questions 
given below concerning the use of inhaled controller 
medications. There were five response options for each 
  question (Table 1).
The self-reported adherence score was calculated from 
the mean of the responses to the four questions.9,11,12 Higher 
scores reflect better adherence to the inhalation regimen. 
For univariate and multivariate analysis, the patients were 
  arbitrarily classified as having good adherence to inhaled 
therapy if the overall mean adherence score was $4.0, while 
a mean score ,4.0 indicated some level of poor adherence.9 
Table 1 Adherence questionnaire
During the last 3 months have you:
1. Been careless about using your inhaler?
2. ever forgotten to use your inhaler?
3. ever stopped using your inhaler because you felt better?
4.   Used your inhaler less than your doctor prescribed because  
you felt better?
responses were as follows:
Most of the time some of the time none of the time
1 2 3 4 5International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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Previous research has shown that self-reported adherence 
using this questionnaire correlates well with adherence 
determined by pharmacy claims data.11
All participants were also asked the following question:9 
Have you been given repeated instruction on inhalation 
technique by a physician at regular intervals? If yes, how? 
Multiple answers (verbal instruction, demonstration, written 
instruction (manufacturer’s pamphlet), and other methods of 
instruction) were acceptable. Improper responses to these 
five questions were excluded from the analysis.
HRQL questionnaire
The St George’s Respiratory Questionnaire (SGRQ) was used 
to measure the HRQL of COPD patients.13,14 The responses 
to its 50 items can be aggregated into a total score and three 
subscores for symptoms (measuring distress caused by 
respiratory symptoms), activities (measuring the effect of 
disturbances to mobility and physical activity), and impacts 
(quantifying the psychosocial impact of the disease). Scores 
range from 0 to 100; higher scores reflect a worse health 
status.13,14 The Japanese version of the SGRQ has been 
validated.15 The SGRQ and the adherence questionnaire were 
given to the patients on the same day.
statistical analysis
All data were analyzed using SPSS for Windows 11.0 
(SPSS Inc., Chicago, IL). Results are given as mean (±SD) 
or median values. Comparisons between groups used the 
Mann–Whitney U test, the χ2 test, or the Kruskal–Wallis 
test for univariate analysis. Correlations between data were 
analyzed using Spearman’s rank correlation test. Multivariate 
analysis using the stepwise method was performed to deter-
mine which of the independent variables were related to good 
adherence to inhalation therapy or good HRQL.   Independent 
variables included age, sex (female = 1, male = 0), frequency 
of respiratory outpatient clinic visits, frequency of adminis-
tration of inhaled medicine, use of DPI + MDI-type inhaler 
devices (yes = 1, no = 0), presence of comorbidities (yes = 1, 
no = 0), taking of antipsychotic drugs (yes = 1, no = 0), 
stage of COPD, and whether repeated instruction for proper 
inhalation technique (yes = 1, no = 0) was given. The level 
of significance was set at P , 0.05.
Results
Characteristics of respondents
Of the 88 patients who were potential participants, 55 responded 
with usable information (62.5% response rate). Thirty-three 
responses had to be excluded due to   unanswered items. 
There were no differences in demographic characteristics 
between respondents and nonrespondents (data not shown). The 
respondents’ data are given in Table 2. Patients were elderly, 
were more often male, and had mild to moderate COPD. 
Patients visited our respiratory outpatient clinic 4–18 times a 
year (median = 8). The mean disease duration was 9 years. Of 
the 55 patients, 37 (67%) had one or more comorbidities, and 13 
(24%) had taken some kind of antipsychotic drugs. All COPD 
patients were under treatment with DPI or/and MDI, such as 
anticholinergic (MDI, or HandiHaler®;   Boehringer Ingelheim, 
Ridgefield, CT), long-acting β2 agonist (Diskhaler® or Diskus®; 
GlaxoSmithKline, London, UK), short-acting β2 agonist via 
MDI, or inhaled corticosteroids (MDI or Diskhaler, Diskus, 
Turbuhaler®;   AstraZeneca, London, UK). Thirty-six patients 
(65.5%) used either DPI or MDI, and 19 patients (34.5%) used 
both DPI and MDI. The average   frequency of administration 
of inhaled medicine was 2.4 times per day.
repeated instruction  
for inhalation technique
Twenty-two (40.0%) of the 55 respondents were provided 
repeated instruction on inhalation technique. All 22 patients 
had their inhalation skills checked repeatedly at regular inter-
vals and were taught how to inhale according to the specific 
characteristics for their particular device during a consultation. 
Of these 22 patients, 18 were given both verbal instructions 
and demonstrations related to inhalation techniques by their 
respiratory physician, and four patients were given only verbal 
instructions on inhalation technique. No patients were given 
written instructions by their respiratory physician.
Background of COPD patients  
with and without good adherence  
to inhaled therapy
The overall mean adherence score in COPD patients was 
4.1 ± 0.7. Of the 55 respondents, 30 (55%) COPD patients 
were classified as having good adherence to inhalation 
therapy, and 25 (45%) showed some levels of poor adherence 
(Table 2). Using univariate analyses, clinical characteristics 
of patients with good adherence to inhalation therapy were 
compared with those of patients with poor adherence. No 
significant differences were found between them regarding 
age, sex, duration of disease, the frequency of visits to 
the respiratory outpatient clinic, period of using inhaled 
medicines, frequency of administration of inhaled medicine, International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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the type of inhaler devices, presence of comorbidities, 
prescribed antipsychotic drugs, and COPD stage. Patients 
who received repeated instruction for proper inhalation 
technique were more prevalent in the group with good 
adherence than in the group with poor adherence (16/14 vs 
6/19, P = 0.033, Table 2).
Multivariate analysis using the stepwise method 
identified which of the factors contributed to good 
  adherence to   inhalation therapy. The final regression 
analysis confirmed that only repeated instruction on 
inhalation technique was positively related to good 
adherence to inhalation therapy (multiple   correlation 
coefficient, 0.28; standardized   coefficient beta, 0.28; 
P = 0.040, Table 3).
Comparison of the mean adherence 
scores for individual items with  
and without repeated instruction  
for COPD patients
The patient group with repeated instruction had a significantly 
greater mean adherence score for the overall mean adherence 
score (4.4 ± 0.5 vs 3.9 ± 0.8; P = 0.032, Figure 1) and the 
item ‘stopped using inhaler because I felt better’ (4.6 ± 0.7 vs 
4.0 ± 1.1; P = 0.049) and showed a marginally greater mean 
adherence score for the item ‘used inhaler less because I felt 
better’ (4.5 ± 0.7 vs 3.9 ± 1.2; P = 0.062) than the group with-
out repeated instruction. There were no significant differences 
between the two groups for the mean adherence scores for the 
other two items of the adherence questionnaire (Table 4).
Correlations between the overall  
mean adherence score and COPD-
related outcomes
The overall mean adherence score showed significant 
  correlations with the SGRQ subscores except for   activities: total: 
r = −0.35, P = 0.023; symptoms: r = −0.43, P = 0.002; activities: 
r = −0.17, P = 0.21; impacts: r = −0.35, P = 0.011 (Table 5).
Comparison of the sgrQ scores 
for COPD patients with and without 
repeated instruction
The group with repeated instruction had   significantly lower 
SGRQ subscores for total (33.7 ±  20.0 vs 44.9 ± 19.2; P = 0.030), 
Table 2 survey respondents’ background and characteristics of patients with and without adherence to inhalation therapy
Total Adherence P value
Good Poor
Patients (number) 55 30 25
Age (years) 69 ± 8 70 ± 8 67 ± 7 0.11
gender (female) 15 8 7 .0.99
Current smoking (yes) 8 6 2 .0.99
Frequency of clinic visitsa (per year) 8 (4–18) 7.5 (4–16) 8 (4–18) 0.80
Duration of disease (years) 9 ± 9 8 ± 9 9 ± 17 0.09
Period of inhaler use (years) 6 ± 6 6 ± 6 5 ± 8 0.10
Frequency of inhaler use (per day) 2.4 ± 1.0 2.3 ± 0.7 2.0 ± 0.6 0.11
Type of inhaler device (DPI, MDI, and DPI + MDI) 18, 18, 19 10, 10, 10 8, 9, 8 0.98
Presence of comorbidities 37 20 17 .0.99
Taking of antipsychotic drugs 13 8 5 0.75
stage of COPD (I, II, III, IV) 13, 30, 9, 3 6, 17, 5, 2 7, 13, 4, 1 0.89
FeV1% predicted value (%) 68.1 ± 16.0 68.4 ± 16.2 67.6 ± 16.2 0.91
FeV1/FVC (%) 56.3 ± 13.1 57.2 ± 13.3 54.0 ± 13.3 0.37
Presence of repeated instruction 22 16 6 0.033
Overall mean adherence score 4.1 ± 0.7 4.6 ± 0.4 3.3 ± 0.3 ,0.001
Notes: aMedian value. Good adherence was defined by an overall mean adherence score $4.0, and poor adherence means score ,4.0.
Abbreviations: DPI, dry powder inhaler; MDI, metered-dose inhaler.
Table 3 Multiple stepwise regression of the variables related to 
the good adherence to inhalation therapy
Standardized  
coefficients beta
t P value
Age   0.22   1.56 0.13
gender −0.06 −0.42 0.68
Frequency of clinic visits −0.01 −0.05 0.96
Frequency of inhaler use   0.19   1.39 0.17
Type of inhaler device −0.02 −0.14 0.89
Comorbidities −0.11   0.71 0.48
Antipsychotic drugs   0.06   0.42 0.68
stage of COPD   0.12   0.86 0.39
repeated instruction   0.28   2.13 0.040
Notes: Adjusted for female sex (yes = 1, no = 0), use of DPI + MDI-type inhaler 
(yes = 1, no = 0), presence of comorbidities (yes = 1, no = 0), taking of antipsychotic 
drugs (yes = 1, no = 0), and presence of repeated instruction (yes = 1, no = 0).
Abbreviations: DPI, dry powder inhaler; MDI, metered-dose inhaler.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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Figure 1 Comparison of overall mean adherence scores between COPD patients with and without repeated instruction for inhalation technique.
instruction were 0.30 and −0.32, P values were 0.023 and 
0.017, respectively, Table 6).
Background of patients who received 
repeated instruction of inhalation  
therapy and those who did not
There were no significant differences between the 22 patients 
who received repeated instruction and the 33 patients who did 
not, regarding age (69.5 ± 9.0 vs 69.0 ± 7.6 years; P = 0.58), 
sex (female/male: 4/18 vs 11/22; P = 0.35), duration of 
COPD (8.0 ± 8.0 vs 8.1 ± 12.3 years; P = 0.59) and stage of 
COPD (I/II/III/IV: 4/13/3/2 vs 9/17/6/1; P = 0.65), presence 
of comorbidities (17 vs 20; P = 0.25), taking of antipsychotic 
drugs (6 vs 7; P = 0.84), frequency of clinic visits (7.9 ± 3.4 
vs 7.8 ± 2.9; P = 0.93), duration of inhaled medicine use 
(7.3 ± 7.7 vs 5.0 ± 5.9 years; P = 0.27), type of inhaler 
devices (DPI/MDI/DPI + MDI: 5/9/8 vs 13/9/11; P = 0.38), 
symptoms (39.1 ± 24.3 vs 52.9 ± 25.8; P = 0.038), and 
impacts (24.3 ± 21.4 vs 36.2 ± 21.3; P = 0.019) and showed 
a marginally lower subscore for activities (42.4 ± 22.9 vs 
50.8 ± 20.9; P = 0.058) than the group without repeated 
instruction.
Factors associated with the total  
sgrQ score in COPD patients
Multivariate analysis was performed to identify the 
  contributing factors related to health status. Multiple 
stepwise regression analysis showed that sex and repeated 
instruction were the significant factors related to the total 
SGRQ score (multiple correlation coefficient was 0.41; 
and standardized coefficient betas for sex and repeated 
Table 4 Comparisons of mean adherence scores for individual 
items between patients with and without repeated instruction
Repeated instruction P value
Yes No
Patients, no. 22 33
Overall mean adherence score 4.4 ± 0.5 3.9 ± 0.8 0.032
Questionnaire item
  Careless about inhaler 4.3 ± 1.1 4.0 ± 1.1 0.16
  Forgot to use inhaler 4.3 ± 1.0 4.0 ± 1.0 0.40
    stopped using inhaler  
because felt better
4.6 ± 0.7 4.0 ± 1.1 0.049
    Used inhaler less  
because felt better
4.5 ± 0.7 3.9 ± 1.2 0.062
Table 5 Correlation between overall mean adherence score and 
sgrQ scores
R P value
SGRQ scores
Total −0.35 0.023
symptoms −0.43 0.002
Activities −0.17 0.21
Impacts −0.35 0.011
Abbreviation: sgrQ, st george’s respiratory Questionnaire.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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frequency of administration of inhaled medicine (2.3 ± 0.7 vs 
2.2 ± 0.7 per day; P = 0.49), and pulmonary function (forced 
expiratory volume in one second [FEV1]% predicted value: 
67.3% ± 17.4% vs 68.6% ± 15.3%; P = 0.72).
Discussion
A cross-sectional study examined the factors related to 
adherence to inhalation regimens in 88 COPD patients 
using univariate and multivariate analyses. Compared to 
patients who did not have good adherence, patients who had 
good adherence to their inhalation regimens had been given 
repeated instruction on inhalation technique. In addition, 
patients who had been given repeated instruction showed 
better quality of life. Furthermore, better adherence to inha-
lation therapy related to better quality of life status assessed 
by the SGRQ.
Adherence to inhalation therapy was found to be poor 
in the present study. Nearly half of the respondents were 
classified as nonadherent to inhalation therapy assessed by 
self-reported questionnaire. This is consistent with studies 
conducted in other countries. Several authors have reported 
that COPD patients were both intentionally and unintention-
ally nonadherent to their therapeutic recommendations.16–18 
Dolce et al investigated adherence to inhalation regimens 
using a self-report adherence questionnaire in 78 COPD 
patients and found that more than half of the patients reported 
missing or skipping doses of their medication.17 COPD 
patients may be especially vulnerable to nonadherence to 
inhalation therapy. James et al examined medication patterns 
using a questionnaire in 185 patients with either asthma 
or COPD. They reported that both groups showed poor 
adherence and that COPD patients had significantly lower 
  adherence levels than asthmatic patients.19 Considering the 
nature of COPD, which is characterized by poor reversibility 
of airflow limitation, COPD patients may have difficulty 
adhering to medications that do not provide immediate 
improvement of symptoms, unlike asthma.19
Several factors, including sociological, psychological, 
patient-related, and physician-based aspects, predis-
pose COPD patients to nonadherence.20–22 Reasons for 
nonadherence have been well studied in COPD, but reasons 
for good adherence are very limited. In the present study, there 
was a significant relationship between repeated instruction for 
inhalation technique and adherence to the inhalation regimen 
assessed by the overall mean adherence score in COPD. The 
clinical effects of educational programs for COPD have been 
widely studied. Recent studies have reported that repeated 
educational programs for COPD including instructions for 
proper inhalation techniques provided by trained nurses or 
general practitioner assistants improved inhalation technique 
and medication adherence.23,24
When considering the reason why repeated instruction 
on inhalation technique in COPD affects adherence to thera-
peutic regimens, the patients’ beliefs and motivations may 
be key factors for inhalation therapy. In our study, when the 
adherence score of each questionnaire item was analyzed, 
patients with repeated instruction showed significantly better 
adherence scores for the question ‘stopped using inhaler 
because I felt better’ and marginally greater scores for the 
item ‘used inhaler less because I felt better’ compared to 
patients without repeated instruction. These two question-
naire items likely represent intentional nonadherent behaviors 
that reflect patients’ beliefs and motivations for treatment 
and illness, in contrast to the other two items that reflect 
accidental nonadherence behavior.25,26 These data suggest 
that repeated instruction may improve intentional nonad-
herence by affecting the patients’ beliefs and motivations to 
adhere to the medication regimen. It has been recognized that 
the crucial role of patients’ perception and beliefs is under-
lined in the medical management of COPD. George et al 
studied 525 COPD patients to identify the predictors of medi-
cation adherence assessed by a self-reported questionnaire 
including 30 items relating to health beliefs, experiences, 
and behaviors. They reported that patients’ beliefs, experi-
ences, and behaviors about both disease and treatment were 
more powerful predictors of medication adherence than 
sociodemographic and clinical factors in COPD patients. 
In multivariate analysis, they also found that the item, 
‘I vary my recommended management based on how I am 
feeling’, was one of the significant independent   predictors 
Table 6 Multiple stepwise regression of the variables related to 
the total sgrQ score
Standardized  
coefficients beta
t P value
Age 0.07 0.55 0.59
gender 0.30 2.35 0.023
Frequency  
of clinic visits
0.02 0.12 0.90
Frequency of inhaler use 0.14 1.03 0.31
Type of inhaler device 0.13 1.03 0.31
Comorbidities 0.19 1.35 0.18
Antipsychotic drugs 0.06 0.42 0.68
stage of COPD 0.01 0.10 0.93
repeated instruction −0.32 −2.48 0.017
Notes: Adjusted for female sex (yes = 1, no = 0), use of DPI + MDI-type inhaler 
(yes = 1, no = 0), presence of comorbidities (yes = 1, no = 0), taking of antipsychotic 
drugs (yes = 1, no = 0), and presence of repeated instruction (yes = 1, no = 0).
Abbreviations: DPI, dry powder inhaler; MDI, metered-dose inhaler.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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of nonadherence.27 Therefore, a patient’s conviction of the 
necessity to use the drug is a key prerequisite for therapy 
adherence in COPD.
Our repeated instruction for inhalation technique may 
have had some advantages in terms of the quality of commu-
nication between medical staff and patients, which reinforced 
patients’ beliefs and motivations to adhere to inhalation 
therapy. Of the 22 patients with repeated instruction, 18 
were given both verbal instructions and demonstrations of 
inhalation technique by their respiratory physician. It has long 
been known that the inclusion of a physical demonstration 
of inhaler technique is more effective than written or verbal 
instructions alone.28,29 Furthermore, repeated instructions for 
inhalation technique were given by respiratory physicians in 
this study. In this regard, not merely the instruction for inhala-
tion technique, but also repeated advice given by physicians 
about inhaled medicines, such as the role of inhaled medi-
cines and their necessity, as well as addressing the patient’s 
concerns about inhaled medicine, might reinforce adherence 
to the treatment regimen.30 In addition, adherence to medica-
tion increases if the prescribing physician is a specialist rather 
than a general practitioner.31
Better adherence to the therapeutic regimen is likely 
related to better clinical outcomes. In the present study, 
adherence to inhaled therapy correlated with the SGRQ 
scores. Furthermore, patients with repeated instruction on 
inhalation technique showed better quality of life scores than 
those who were not given repeated instruction. To clarify 
the relationships between repeated instruction, medication 
adherence, and health status, multivariate analysis using a 
stepwise method was performed to identify the contribut-
ing factors related to the total SGRQ score. We found that 
repeated instruction was one of the significant factors related 
to better health status. Given that repeated instruction was 
the common contributing factor related to better adherence 
to inhalation therapy and better health status, the relationship 
between medication adherence and HRQL in COPD may 
be mediated through our repeated instruction on inhalation 
technique. However, the association between adherence to 
therapeutic regimen and quality of life in COPD is still a 
matter of debate. Most educational programs have found 
negative or inconclusive results regarding HRQL.24,32 Further 
research needs to address this.
Some limitations of our study should be noted. Because 
of an observational, cross-sectional study, no cause-effect 
relationship can be established. Furthermore, other limita-
tions of the present study are its small sample size and the 
fact that repeated instruction was neither randomized nor 
controlled due to the cross-sectional nature of the study. 
There may have been a possible bias in the selection of 
periodic instruction for each patient. We tested the extent 
of selection bias by comparing the patients’ background 
characteristics for patients with and without repeated instruc-
tion. There were no differences between them regarding all 
variables we investigated.
To assess medication adherence, there exists a variety 
of methods, such as medication counting, diaries, electronic 
monitoring, and analysis of pharmacy claims databases. 
However, there is no universal definition of adherence that 
could be used as a gold standard at present. The adherence 
data of the present study were based on self-reports from 
patients. Most investigations of self-reports indicate that 
patients bias information in a positive direction,22 suggesting 
that it is more likely that adherence may have been overes-
timated in this study.
Conclusion
The present study demonstrates the significant relation-
ships between repeated instruction for inhalation technique, 
  adherence to inhalation therapy, and HRQL in COPD. Iden-
tification and management of adherence-related factors in 
COPD may improve the health status of patients with COPD. 
Prospective, longitudinal studies are needed to investigate 
the mechanisms of how repeated instruction for inhalation 
technique correlate with adherence to the inhalation regimen 
and clinical outcomes for COPD.
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